Zhou Shaoman, Kern Earl R, Gullen Elizabeth, Cheng Yung-Chi, Drach John C, Matsumi Shintaro, Mitsuya Hiroaki, Zemlicka Jiri
Department of Chemistry, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201-1379, USA.
J Med Chem. 2004 Dec 30;47(27):6964-72. doi: 10.1021/jm040093l.
The Z- and E-isomers of fluoromethylenecyclopropane analogues 11a-d and 12a-d were synthesized, and their antiviral activities were evaluated. The purine (Z,E)-methylenecyclopropane carboxylates 13 and 24 were selectively fluorinated using lithium diisopropylamide, LiCl, and N-fluorobenzenesulfonimide to give (Z,E)-fluoroesters 22 and 25. Reduction with LiBH(4) or diisobutylaluminum hydride gave after chromatographic separation Z-isomers 11a and 11e and E-isomers 12a and 12e. The O-demethylation of 11e and 12e afforded guanine analogues 11b and 12b. Fluorination of (Z,E)-cytosine and thymine esters 15 and 16 afforded (Z,E)-fluoroesters 26 and 27, which were resolved before the reduction to analogues 11c and 11d and 12c and 12d. Adenine Z-isomer 11a was the most effective against Towne and AD169 strains of human cytomegalovirus (HCMV, EC(50) 3.6 and 6.0 microM, respectively), but it was less effective against murine virus (MCMV, EC(50) 69 microM). Thymine Z-isomer 11d was effective against HSV-1 in BSC-1 cells (ELISA, EC(50) 2.5 microM) but inactive against HSV-1 or HSV-2 in Vero or HFF cells. All of the analogues with the exception of 12d were effective at least in one of the assays against Epstein-Barr virus (EBV) in Daudi or H-1 cells in a micromolar or submicromolar range. Cytosine and thymine Z-isomers 11c and 11d were active against varicella zoster virus (VZV) with EC(50) 0.62 microM. Adenine Z- and E-isomers 11a and 12a were effective against HIV-1 in MT-2 or MT-4 cells with EC(50) 12-22 and 2.3-7.6 microM, respectively, whereas only 12a was effective against hepatitis B virus (HBV) with EC(50) 15 microM. Analogues 11a and 12a were weak substrates for adenosine deaminase.
合成了氟亚甲基环丙烷类似物11a - d和12a - d的Z -异构体和E -异构体,并评估了它们的抗病毒活性。使用二异丙基氨基锂、LiCl和N -氟苯磺酰亚胺对嘌呤(Z,E) -亚甲基环丙烷羧酸盐13和24进行选择性氟化,得到(Z,E) -氟代酯22和25。用LiBH(4)或二异丁基氢化铝还原,经色谱分离后得到Z -异构体11a和11e以及E -异构体12a和12e。11e和12e的O -去甲基化反应得到鸟嘌呤类似物11b和12b。(Z,E) -胞嘧啶和胸腺嘧啶酯15和16的氟化反应得到(Z,E) -氟代酯26和27,在还原为类似物11c和11d以及12c和12d之前进行了拆分。腺嘌呤Z -异构体11a对人巨细胞病毒(HCMV)的Towne株和AD169株最有效(EC(50)分别为3.6和6.0 microM),但对鼠病毒(MCMV,EC(50)为69 microM)效果较差。胸腺嘧啶Z -异构体11d在BSC - 1细胞中对单纯疱疹病毒1型(HSV - 1)有效(ELISA法,EC(50)为2.5 microM),但在Vero或HFF细胞中对HSV - 1或HSV - 2无活性。除12d外,所有类似物在针对Daudi或H - 1细胞中爱泼斯坦 - 巴尔病毒(EBV)的至少一种检测中,在微摩尔或亚微摩尔范围内有效。胞嘧啶和胸腺嘧啶Z -异构体11c和11d对水痘带状疱疹病毒(VZV)有活性,EC(50)为0.62 microM。腺嘌呤Z -异构体和E -异构体11a和12a在MT - 2或MT - 4细胞中对人类免疫缺陷病毒1型(HIV - 1)有效,EC(50)分别为12 - 22和2.3 - 7.6 microM,而只有12a对乙型肝炎病毒(HBV)有效,EC(50)为15 microM。类似物11a和12a是腺苷脱氨酶的弱底物。